Kybella is the first and only FDA approved injectable drug that contours and improves the appearance of submental fullness, sometimes called "double chin", and Rockwall Dermatology is the first clinic in Rockwall, TX to offer it.

Kybella at Rockwall Dermatology

Dr. Jessica Saucier, a Board Certified Dermatologist and Allergan Master Injector, performs every Kybella procedure at Rockwall Dermatology and personalizes each Kybella treatment regimen based on each patient's goals and needs. Watch the video to see Dr. Saucier administer a Kybella treatment at Rockwall Dermatology.

Read more about Dr. Saucier here or read on to learn more about Kybella at Rockwall Dermatology.

Request an Appointment


A consultation with Dr. Saucier is necessary to assess your own goals and unique needs. A consultation fee of $100 is applied to your visit and can be immediately transferred to your customized treatment plan.


"Dr. Saucier is very caring and gentle. She thoroughly explained the procedure and made sure that I was comfortable with each and every step. She is just the best doctor I have every seen!"

Read morequotes
Kybella results

Is Kybella right for me?

A consultation with Dr. Saucier will establish this, but Kybella may be right for you if:

  • You're bothered by submental fullness or "double chin",
  • Surgery is not an option for you,
  • You feel the condition makes you look older or heavier than you actually are, and/or
  • You eat well and exercise, but submental fullness does not go away.
According to a 2015 survey conducted by the American Society for Dermatologic Surgery, nearly as many consumers are bothered by their double chin (67%) as by lines and wrinkles around the eyes (69%).

Individual results may vary.

How does Kybella work?

When injected into subcutaneous fat, Kybella causes the destruction of fat cells. Once destroyed, those cells cannot store or accumulate fat. In clinical studies, many patients experienced visible results in two to four treatment sessions spaced at least one month apart. Up to six treatments may be administered, and each treatment session is typically 15-20 minutes.

Is there downtime after Kybella treatments?

For most of the 1600+ patients in more than 20 clinical studies, downtime was minimal and occurred most commonly after the first treatment session. Our experience with Kybella at Rockwall Dermatology has been similar. As with other injectable treatments, you may experience side effects with Kybella. The most common side effects are swelling, bruising, pain, numbness, redness, and areas of hardness in the treatment area.

Kybella (deoxycholic acid) injection 10 mg/mL

What is Kybella?

Kybella (deoxycholic acid) injection is indicated for improvement in the appearance of moderate to severe convexity or fullness associated with submental fat in adults. Kybella is a non-human and non-animal formulation of deoxycholic acid, a naturally-occurring molecule in the body that aids in the breakdown and absorption of dietary fat.

Indication and Important Safety Information

Kybella (deoxycholic acid) injection is indicated for improvement in the appearance of moderate to severe convexity or fullness associated with submental fat in adults. The safe and effective use of Kybella for the treatment of subcutaneous fat outside the submental region has not been established and is not recommended.


Kybella is contraindicated in the presence of infection at the injection sites.

Warnings and Precautions

  • Marginal Mandibular Nerve Injury

    Cases of marginal mandibular nerve injury, manifested as an asymmetric smile or facial muscle weakness, were reported in 4% of subjects in the clinical trials; all cases resolved spontaneously (range 1-298 days, median 44 days). Kybella should not be injected into or in close proximity to the marginal mandibular branch of the facial nerve.

  • Dysphagia

    Dysphagia occurred in 2% of subjects in the clinical trials in the setting of administration-site reactions, eg, pain, swelling, and induration of the submental area; all cases of dysphagia resolved spontaneously (range 1- 81 days, median 3 days). Avoid use of Kybella in patients with current or prior history of dysphagia as treatment may exacerbate the condition.

  • Injection-Site Hematoma/Bruising

    In clinical trials, 72% of subjects treated with Kybella experienced hematoma/bruising. Kybella should be used with caution in patients with bleeding abnormalities or who are currently being treated with antiplatelet or anticoagulant therapy as excessive bleeding or bruising in the treatment area may occur.

  • Risk of Injecting Into or in Proximity to Vulnerable Anatomic Structures

    To avoid the potential of tissue damage, Kybella should not be injected into or in close proximity (1 cm-1.5 cm) to salivary glands, lymph nodes, and muscles.

Adverse Reactions

The most commonly reported adverse reactions in the pivotal clinical trials were: injection site edema/swelling, hematoma/bruising, pain, numbness, erythema, and induration.

Please see Kybella full prescribing information.

Cosmetic Dermatology

Ask a question.

We only use your information to respond.
  I am a new patient.
  I agree with terms and privacy policy.

Kybella Fact Sheet

Kybella Fact Sheet